Randomized controlled trial of nalfurafine for refractory pruritus in hemodialysis patients

Background: Chronic kidney disease-associated pruritus (CKD-aP) is very common and sometimes refractory to treatment in hemodialysis patients. In a trial conducted in Japan, nalfurafine, effectively reduced itching of treatment-resistant CKD-aP. Our present bridging study aimed to evaluate the effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ping, Xiang, Shilong, Liu, Bicheng, Wang, Xiaohui, Yang, Xiaoping, Ye, Chaoyang, Wang, Zunsong, Li, Yanlin, Zhou, Li, Wang, Caili, Li, Hongbo, Huang, Jian, Peng, Ai, Wang, Xiaoping, Wang, Deguang, Xiao, Jie, Chen, Wenli, Cheng, Hong, Mao, Nan, Wang, Jianqin, Yang, Lin, Chen, Jianghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980412/
https://www.ncbi.nlm.nih.gov/pubmed/36856148
http://dx.doi.org/10.1080/0886022X.2023.2175590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980412/
https://www.ncbi.nlm.nih.gov/pubmed/36856148
http://dx.doi.org/10.1080/0886022X.2023.2175590

Ejemplares similares